Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
$43.80
-5.1%
$58.94
$37.29
$69.98
$28.34B1.349.05 million shs15.13 million shs
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
$48.84
-1.3%
$48.28
$44.70
$71.19
$45.90B1.5110.25 million shs7.89 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.20
+0.8%
$26.06
$24.48
$31.54
$142.93B0.6139.04 million shs32.32 million shs
Seagen Inc. stock logo
SGEN
Seagen
$228.74
$228.74
$123.77
$228.96
$42.93B0.321.48 million shs86 shs
The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
0.00%-6.59%-26.66%-28.51%-7.43%
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
0.00%+1.53%+0.43%+0.58%-23.93%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%-3.83%-3.39%-5.33%-9.25%
Seagen Inc. stock logo
SGEN
Seagen
0.00%0.00%0.00%0.00%0.00%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
4.9915 of 5 stars
4.55.02.50.63.32.53.8
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
4.492 of 5 stars
3.13.02.50.02.63.32.5
Pfizer Inc. stock logo
PFE
Pfizer
4.9866 of 5 stars
3.33.04.24.23.33.33.1
Seagen Inc. stock logo
SGEN
Seagen
0.714 of 5 stars
0.00.00.02.50.63.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
3.07
Buy$76.2974.20% Upside
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
2.24
Hold$59.8222.47% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.63
Moderate Buy$31.9226.67% Upside
Seagen Inc. stock logo
SGEN
Seagen
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest PFE, SGEN, DAL, and OXY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/26/2025
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$63.00 ➝ $58.00
3/18/2025
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$80.00 ➝ $72.00
3/18/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/17/2025
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$56.00 ➝ $51.00
3/13/2025
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$59.00 ➝ $52.00
3/12/2025
Pfizer Inc. stock logo
PFE
Pfizer
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/11/2025
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$90.00 ➝ $77.00
3/11/2025
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$90.00 ➝ $80.00
3/10/2025
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Outperform$81.00 ➝ $64.00
3/10/2025
Pfizer Inc. stock logo
PFE
Pfizer
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/6/2025
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$51.00 ➝ $50.00
(Data available from 3/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
$61.64B0.46$6.92 per share6.33$23.66 per share1.85
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
$26.73B1.72$11.23 per share4.35$27.91 per share1.75
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.25$3.95 per share6.38$15.81 per share1.59
Seagen Inc. stock logo
SGEN
Seagen
$2.30B18.66N/AN/A$15.10 per share15.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
$3.46B$5.338.225.290.755.61%30.41%5.30%4/9/2025 (Estimated)
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
$4.70B$2.4420.0212.69N/A11.37%16.33%5.05%5/6/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.4117.878.320.6412.62%19.47%8.09%4/29/2025 (Estimated)
Seagen Inc. stock logo
SGEN
Seagen
-$610.31M-$4.01N/AN/AN/A-32.61%-28.06%-20.92%N/A

Latest PFE, SGEN, DAL, and OXY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/9/2025N/A
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
$0.84N/AN/AN/A$13.85 billionN/A
2/18/2025Q4 2024
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
$0.67$0.80+$0.13-$0.32$7.14 billion$6.84 billion
2/4/2025Q4 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.48$0.63+$0.15$0.07$17.26 billion$17.76 billion
1/10/2025Q4 24
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
$1.76$1.85+$0.09$1.29$14.20 billion$15.56 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
$0.601.37%N/A11.26%N/A
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
$0.961.97%+180.20%39.34%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.83%+2.50%121.99%16 Years
Seagen Inc. stock logo
SGEN
Seagen
N/AN/AN/AN/AN/A

Latest PFE, SGEN, DAL, and OXY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/18/2025
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
quarterly$0.241.7%3/10/20253/10/20254/15/2025
2/6/2025
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
quarterly$0.150.88%2/27/20252/27/20253/20/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
0.92
0.37
0.32
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
0.95
0.95
0.76
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73
Seagen Inc. stock logo
SGEN
Seagen
N/A
2.67
2.12

Institutional Ownership

CompanyInstitutional Ownership
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
69.93%
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
88.70%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Seagen Inc. stock logo
SGEN
Seagen
84.26%

Insider Ownership

CompanyInsider Ownership
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
0.96%
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
0.31%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Seagen Inc. stock logo
SGEN
Seagen
25.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Delta Air Lines, Inc. stock logo
DAL
Delta Air Lines
95,000646.47 million640.27 millionOptionable
Occidental Petroleum Co. stock logo
OXY
Occidental Petroleum
12,000939.78 million935.59 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
83,0005.67 billion5.66 billionOptionable
Seagen Inc. stock logo
SGEN
Seagen
3,256187.70 million139.08 millionOptionable

Recent News About These Companies

Seagen posts breast cancer win ahead of Pfizer takeover
Is Merck planning a $30bn-plus move for Seagen?
Franklin Biotechnology Discovery C
Pfizer: Turning The Corner (Rating Upgrade)
MRNA Feb 2024 64.000 put
MRNA Feb 2024 77.000 call
MRNA Feb 2024 67.000 put

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Delta Air Lines stock logo

Delta Air Lines NYSE:DAL

$43.80 -2.36 (-5.10%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$43.75 -0.05 (-0.10%)
As of 03/28/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Delta Air Lines, Inc. provides scheduled air transportation for passengers and cargo in the United States and internationally. The company operates through two segments, Airline and Refinery. Its domestic network centered on core hubs in Atlanta, Minneapolis-St. Paul, Detroit, and Salt Lake City, as well as coastal hub positions in Boston, Los Angeles, New York-LaGuardia, New York-JFK, and Seattle; and international network centered on hubs and market presence in Amsterdam, Bogota, Lima, Mexico City, London-Heathrow, Paris-Charles de Gaulle, Sao Paulo, Seoul-Incheon, and Tokyo. The company sells its tickets through various distribution channels, including delta.com and the Fly Delta app; acts as a reservations specialists; and operates online travel and traditional brick and mortar agencies. It also provides aircraft maintenance and engineering support, repair, and overhaul services; and vacation packages to third-party consumers. The company operates through a fleet of approximately 1,273 aircrafts. Delta Air Lines, Inc. was founded in 1924 and is based in Atlanta, Georgia.

Occidental Petroleum stock logo

Occidental Petroleum NYSE:OXY

$48.84 -0.67 (-1.35%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$48.75 -0.09 (-0.19%)
As of 03/28/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Occidental Petroleum Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of oil and gas properties in the United States, the Middle East, and North Africa. It operates through three segments: Oil and Gas, Chemical, and Midstream and Marketing. The company's Oil and Gas segment explores for, develops, and produces oil and condensate, natural gas liquids (NGLs), and natural gas. Its Chemical segment manufactures and markets basic chemicals, including chlorine, caustic soda, chlorinated organics, potassium chemicals, ethylene dichloride, chlorinated isocyanurates, sodium silicates, and calcium chloride; and vinyls comprising vinyl chloride monomer, polyvinyl chloride, and ethylene. The Midstream and Marketing segment gathers, processes, transports, stores, purchases, and markets oil, condensate, NGLs, natural gas, carbon dioxide, and power. This segment also invests in entities. Occidental Petroleum Corporation was founded in 1920 and is headquartered in Houston, Texas.

Pfizer stock logo

Pfizer NYSE:PFE

$25.20 +0.19 (+0.76%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$25.14 -0.07 (-0.26%)
As of 03/28/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Seagen stock logo

Seagen NASDAQ:SGEN

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington. As of December 14, 2023, Seagen Inc. operates as a subsidiary of Pfizer Inc.